Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Equity Average (2019 - 2025)

Historic Equity Average for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $64.6 million.

  • Pulmonx's Equity Average fell 3382.01% to $64.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.6 million, marking a year-over-year decrease of 3382.01%. This contributed to the annual value of $102.1 million for FY2024, which is 2504.31% down from last year.
  • As of Q3 2025, Pulmonx's Equity Average stood at $64.6 million, which was down 3382.01% from $73.4 million recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Equity Average registered a high of $221.1 million during Q1 2021, and its lowest value of $64.6 million during Q3 2025.
  • Its 5-year average for Equity Average is $141.9 million, with a median of $138.9 million in 2023.
  • Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 195802.55% in 2021, then tumbled by 3382.01% in 2025.
  • Over the past 5 years, Pulmonx's Equity Average (Quarter) stood at $198.0 million in 2021, then decreased by 19.84% to $158.7 million in 2022, then decreased by 23.13% to $122.0 million in 2023, then dropped by 26.36% to $89.9 million in 2024, then dropped by 28.16% to $64.6 million in 2025.
  • Its last three reported values are $64.6 million in Q3 2025, $73.4 million for Q2 2025, and $81.7 million during Q1 2025.